Nuvation Bio Inc. (NUVB-WT) Stock Overview
Explore Nuvation Bio Inc.’s financial performance, market position, analyst ratings, and future outlook.
Nuvation Bio Inc. (NUVB-WT)
Key Financials
Key Financials
Market Cap
23.7M
P/E Ratio
-11.32
EPS (TTM)
N/A
ROE
-0.44%
NUVB-WT Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Nuvation Bio Inc. (NUVB-WT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 51.44, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.30.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -11.32 and a market capitalization of 23.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.